3D QSAR analysis of some heterocyclic compounds as cyclooxygenase- 2 inhibitors

Medicinal Chemistry Research

Volumn 13, Issue 6-7, 2004, Pages 337-347

  Despande, S V ^a   Babu, M Arockia ^a   Gupta, A K ^a   Kaskhedikar, S G ^a   Saxena, A K ^b  

^a SHRI G S INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

^b Medicinal Chemistry Division   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; HETEROCYCLIC COMPOUND; TRIAZOLE DERIVATIVE;

ANIMAL CELL; CONFERENCE PAPER; CORRELATION ANALYSIS; DRUG BINDING SITE; DRUG PROTEIN BINDING; ENZYME INHIBITION; EXPERT SYSTEM; HYDROPHOBICITY; NONHUMAN; PHYSICAL CHEMISTRY; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; STRUCTURE ANALYSIS;

EID: 20344394926     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00044-004-0039-1     Document Type: Conference Paper

References (15)

1. Vane, J.R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin like drugs. Nature. 1971, 231(25), 232-235.
2. Hla, T.; Neilson, K. Human cyclooxygenase-2 cDNA. Proc. Natl. Acad. Sci. USA, 1992, 89(16), 7384-7388.
3. Xie, W.; Chipman, J.G.; Robertson, D.L.; Erikson, R.L.; Simmons, D.L. Expression of a mitogen-response gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc. Natl. Acad. Sci. USA, 1991, 88, 2692-2696.
4. Masferrer, J.L.; Zweifer, B.S.; Manning, P.T.; Houser, S.D.; Leathey, K.M.; Simith, W.G.; Isakson, P.C.; Seibert, K. Selective inhibition of inducible cyclooxygenase-2 invivo antiinflammatory and non ulcerogenic. Proc. Natl. Acad. Sci. USA, 1994, 91(8), 3228-3232.
5. Seibert, K.; Masferrer, J.L. Role of inducible cyclooxygenase (COX-2) in inflammation. Receptor. 1994, 4(1), 17-23.
6. Meade, E.A.; Smith, V.L.; Dewitt, D.L. Differential inhibition of prostaglandin endoperoxidase synthase (Cyclooxygenase) isoenzymes by aspirin and other nonsteroidal antiinflammatory drugs. J. Biol. Chem. 1993, 268(4), 6610-6614.
7. Mitchell, J.A.; Akaraserermont, P.; Thiemrman, C.; Flower, R.J.; Vane, J.R. Selectivity of nonsteroidal antiinflammatory drugs as inhibitor of constitutive and inducible cyclooxygenase. Proc. Natl. Acad. Sci. USA, 1993, 90(24), 11693-11697.
8. Roy, P.; Leblanc, Y.; Ball, R.G.; Brudeau, C.; Chan, C.C.; Chauret, N.; Cromlish, W.; Ethier, D.; Gauthier, J.Y.; Gordon, R.; Greig, G.; Guay, J.; Kargman, S.; Lau, C.K.; Neil, G.; Sliva, J.; Therien, M.; Van staden, C.; Wong, E.; Xu, L.; Prasit, P. A series of selective COX-2 inhibitors: 5,6 Diarylthiazolo [3,2-b][1,2,4] triazoles. Bioorg. Med. Chem. Lett. 1997, 7(1), 57-62.
9. Hansch, C.; Leo, A.; Unger, S.H.; Kim, K.H.; Nikaitani, D.; Lien, E.J. "Aromatic" substituent constants for structure activity correlations. J. Med. Chem. 1973, 16(11), 1207-16.
10. Hansch, C.; Leo, A. Substitution constants for correlation Analysis in Chemistry and Biology; wiley-interscience; New York, 1979; pp 48-63.
11. Insight II, Version 2.3.0, BioSym Technologies, San Diego (1993).
12. Ghose, A.K.; Crippen, G.M. Aromatic physical chemical parameters for the three dimensional structure directed quantitative structure activity relationships 2. Modeling dispersive and hydrophobic interaction. J. Chem. Inf. Comput. Chem. 1987, 27(1), 21-35.
13. Viswanathan, V.N.; Ghose, A.K.; Revankar, G.R.; Robin, R.K. Aromatic physicochemical parameters for three dimensional structure directed quantitative structure-activity relationship 4. Additional parameters for hydrophobic and dispersive interaction and their application for an automated superimposition of certain naturally occuring nucleoside antibiotics. J. Chem. Inf. Comput. Sci. 1989, 29(1), 163-172.
14. Golender, V.E.; Vorpogel, E.R. In 3D-QSAR in Drug Design, Theory, Methods and Applications, ed.; Kubinyi, H., Eds.; ESCOM Science Publications: Leiden, 1993; pp 137.
15. APEX-3D User Guide, Molecular Simulation Inc., San Diego, 1995.